focus -WSS

focus

author：explore 2025-10-01 04:11:44 - browse：2

the U.S. Medicare Handbook is photographed in Washington. — Pablo Martinez Monsivais/AP

Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program.

Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s, according to new federal Medicare Advantage enrollment data analyzed by STAT.

The data reinforce how America’s Medicare program continues to shift toward a more privatized version that has not saved any money for taxpayers, has been linked to inappropriate coding practices, and has restricted care for older and vulnerable patients. And even though the federal government made several changes to Medicare Advantage for 2024 — changes that were vehemently opposed by the health insurance industry — the program’s growth has not been stunted, nor did insurers dramatically slash their offerings.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Male doctors called my cancer incurable. A female doctor showed it wasn't

WSS

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Chimpanzees, like humans and whales, get menopause: Study

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Medicare Advantage overpayments discussion gets experts fired up

Physician subsidies by hospitals soar in wake of No Surprises Act

Traditional Chinese medicine benefits explored in new JAMA study

knowledge

focus

hotspot

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Psychedelics group wrestles with new pharma identity

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Psychedelics group wrestles with new pharma identity

Maker of FluMist seeks to allow at

Activists slam private health insurers over coverage restrictions

Life science postdocs should get big pay hike, NIH panel says

New air purifier tech could be key to improving indoor air quality

Traditional Chinese medicine benefits explored in new JAMA study

focus

Traditional Chinese medicine benefits explored in new JAMA study

FDA has safety concerns on CRISPR

Profiling embryos to choose those with higher IQs is almost a reality

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Hospitals warn Medicare's drug payment fix is ‘unlawful’

A preacher's new calling: Diversifying neuroscience research

hotspot

focus

entertainment

leisure time